91 4E-BP1 expression levels determine sensitivity of triple negative breast cancer cells to mTOR inhibitors

2014 ◽  
Vol 50 ◽  
pp. 34
Author(s):  
K. Jastrzebski ◽  
B. Thijssen ◽  
J. Vidal Rodriguez ◽  
K. de Lint ◽  
C. Lieftink ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cancer Cells ◽  
Triple Negative Breast Cancer ◽  
Breast Cancer Cells ◽  
Triple Negative ◽  
Mtor Inhibitors ◽  
Expression Levels

scholarly journals β-TrCP1 degradation is a novel action mechanism of PI3K/mTOR inhibitors in triple-negative breast cancer cells

2015 ◽  
Vol 47 (2) ◽  
pp. e143-e143 ◽  
Author(s):  
Yong Weon Yi ◽  
Hyo Jin Kang ◽  
Edward Jeong Bae ◽  
Seunghoon Oh ◽  
Yeon-Sun Seong ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cancer Cells ◽  
Triple Negative Breast Cancer ◽  
Breast Cancer Cells ◽  
Triple Negative ◽  
Mtor Inhibitors ◽  
Action Mechanism

MiRNAs-181a/b as Predictive biomarkers for olaparib sensitivity in triple-negative breast cancer cells.

2017 ◽  
Vol 12 (1) ◽  
pp. 221-229
Author(s):  
Abeer M. Ashmawy ◽  
Mona A. Sheta ◽  
Faten Zahran ◽  
Abdel Hady A. Abdel Wahab
Keyword(s):  
Breast Cancer ◽  
Cancer Cells ◽  
Triple Negative Breast Cancer ◽  
Breast Cancer Cells ◽  
Triple Negative ◽  
Predictive Biomarkers

microRNA-506-3p suppresses the proliferation of triple negative breast cancer cells via targeting SNAI2

2021 ◽  
Vol 17 (4) ◽  
pp. 513-522
Author(s):  
Xuye Zhao ◽  
Xiangdong Bai ◽  
Weina Li ◽  
Xuezhen Gao ◽  
Xiaoli Wang ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cancer Cells ◽  
Triple Negative Breast Cancer ◽  
Breast Cancer Cells ◽  
Triple Negative
Sign in / Sign up

Export Citation Format

Share Document